Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
02/03/2019 | 01h13 | Dow Jones News | Synergy Pharmaceuticals Is Approved to Sell Assets to Bausch Health | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
27/02/2019 | 01h07 | Dow Jones News | Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc. | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
17/12/2018 | 21h43 | Dow Jones News | Synergy Pharmaceuticals Up 55% on Trulance Progress in Canada | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
12/12/2018 | 17h10 | Dow Jones News | Former Pharma Highflier Appreciates Bathroom Humor -- Overheard | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
12/12/2018 | 14h18 | Dow Jones News | Bausch Health to Buy Synergy Pharmaceuticals Out of Bankruptcy for $200 Million--Update | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
12/12/2018 | 13h14 | Dow Jones News | Bausch Health Agrees to Buy Synergy Pharmaceuticals for $200 Million | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
03/01/2012 | 22h44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
03/01/2012 | 22h15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
03/01/2012 | 22h15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
27/12/2011 | 22h05 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
22/12/2011 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
21/12/2011 | 18h18 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(3) (424B3) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
19/12/2011 | 23h04 | Edgar (US Regulatory) | Securities Registration Statement (simplified form) (S-3/A) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
16/12/2011 | 20h35 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
13/12/2011 | 22h41 | Business Wire | Synergy Pharmaceuticals Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp. | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
13/12/2011 | 17h56 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
13/12/2011 | 14h00 | PR Newswire (US) | Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior V... | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
13/12/2011 | 09h00 | Business Wire | Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. & its Chief Scientific Officer & Senior VP of... | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
08/12/2011 | 22h29 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
08/12/2011 | 22h29 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
08/12/2011 | 22h28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
08/12/2011 | 22h27 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
08/12/2011 | 22h26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
07/12/2011 | 16h31 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
06/12/2011 | 23h00 | Business Wire | Synergy Pharmaceuticals Announces Closing of Public Offering of 1,875,000 Units | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
01/12/2011 | 23h17 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
01/12/2011 | 23h14 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(2) (424B2) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
01/12/2011 | 14h00 | Business Wire | Synergy Pharmaceuticals Inc. Announces Pricing of Public Offering of 1,875,000 Units, Listing on NASDAQ & Effectiveness of Re... | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |